Labtec
AdhexPharma is an independent contract development and manufacturing organization (CDMO) specializing in oral films and transdermal or topical patches for drug delivery. The company provides comprehensive end-to-end services from feasibility studies and formulation to analytical development, clinical batch production, and commercial manufacturing under cGMP. With expertise in complex dosage forms, handling potent APIs, and meeting global regulatory requirements, AdhexPharma integrates sustainable practices and operates advanced facilities in France and Germany, supporting both large pharmaceutical firms and biotech innovators worldwide.
Industries
Nr. of Employees
medium (51-250)
Products
Oral film drug delivery systems
Oral films, including orodispersible formats, designed for fast-dissolving, buccal, or sublingual administration. Provide customized drug release and support for complex APIs.
Transdermal patch drug delivery systems
Adhesive patch technologies for controlled, continuous transdermal drug delivery across multiple therapeutic areas such as pain management, hormone replacement, nicotine replacement, cardiovascular conditions, and mental health.
Oral film drug delivery systems
Oral films, including orodispersible formats, designed for fast-dissolving, buccal, or sublingual administration. Provide customized drug release and support for complex APIs.
Transdermal patch drug delivery systems
Adhesive patch technologies for controlled, continuous transdermal drug delivery across multiple therapeutic areas such as pain management, hormone replacement, nicotine replacement, cardiovascular conditions, and mental health.
Services
Contract development for patches and oral films
Product development from feasibility studies through formulation optimization, process scale-up, technology transfer, and preparation of validation batches for oral film and patch drug delivery systems.
Contract manufacturing for pharmaceutical products
Manufacturing of oral films and patches under cGMP, EMA, and FDA-compliant conditions from pilot to full commercial scale, including handling of high-potency APIs and hormones.
Analytical services for drug delivery systems
Development, validation, and transfer of analytical methods; routine quality control; ICH-compliant stability studies; and specific analytics for transdermal and oral film dosage forms.
Licensing of oral film and transdermal patch products
Licensing agreements for market-ready drug delivery products in oral film and transdermal patch formats, enabling rapid partner commercialization.
Contract development for patches and oral films
Product development from feasibility studies through formulation optimization, process scale-up, technology transfer, and preparation of validation batches for oral film and patch drug delivery systems.
Contract manufacturing for pharmaceutical products
Manufacturing of oral films and patches under cGMP, EMA, and FDA-compliant conditions from pilot to full commercial scale, including handling of high-potency APIs and hormones.
Analytical services for drug delivery systems
Development, validation, and transfer of analytical methods; routine quality control; ICH-compliant stability studies; and specific analytics for transdermal and oral film dosage forms.
Licensing of oral film and transdermal patch products
Licensing agreements for market-ready drug delivery products in oral film and transdermal patch formats, enabling rapid partner commercialization.
Expertise Areas
- Drug delivery system development
- Transdermal patch technology
- Oral film and orodispersible film technology
- Analytical method development and validation
Key Technologies
- Transdermal drug delivery
- Oral film drug delivery
- Orodispersible film technology
- Hot-melt extrusion